Analysis of mitochondrial function in lymphocytes obtained from COVID-19 patients

CONCLUSION: SCMM-CD8 could act as a diagnostic biomarker of COVID-19 progression. However, this needs to be verified in other multi-center studies with a larger sample size.PMID:37889851 | PMC:PMC10612433 | DOI:10.1177/03946320231210736
Source: International Journal of Immunopathology and Pharmacology - Category: Allergy & Immunology Authors: Source Type: research